WOONSOCKET, R.I., May 25, 2011 /PRNewswire/ -- A new study by researchers at Harvard University,
In a study published online this week in the Journal of the American Pharmacists Association (JAPhA) the researchers said, "Approximately one-half of caregivers reported they are more likely to forgo their own medications than the medication needs of their caregivees, especially if cost was a problem, and that caring for their family members was more important than caring for themselves." The researchers added, "Our findings indicate care-giving status may be an important characteristic for providers to identify and that caregivers may represent a fertile target for adherence interventions to improve chronic disease management and prevent chronic disease."
The latest study is a product of CVS Caremark's three-year collaboration with Harvard University and Brigham and Women's Hospital to research pharmacy claims data to better understand patient behavior, and how the health care system can improve it, particularly around medication adherence. The JAPhA study was published as CVS Caremark is sponsoring a forum on adherence at the National Press Club in Washington, D.C., to discuss the research findings of its collaboration and to outline future research and program initiatives the company is pursuing to address the problem that is estimated to cost the U.S. health care system almost $300 billion annually.
For the JAPhA study, the research team conducted an online survey of 2,000 retail pharmacy customers of which 38 percent, or 762 respondents, described themselves as caregivers. Of that group:
"We found there is a compelling relationship between care giving and medication adherence," said William Shrank, MD, MSHS, of Brigham and Women's Hospital and Harvard Medical School and lead author of the study. "Caregivers appear to be so focused on helping family members that they often forget to take care of themselves, behavior that can have severe consequences for their health and well-being. Health care professionals should identify and target this group to help them better manage their personal health while caring for family members."
"These results highlight an important opportunity for our industry to work with a target population to increase adherence," said Troyen A. Brennan, executive vice president and chief medical officer of CVS Caremark, and a co-author of the study. "Doctors need to identify caregivers so they can provide appropriate support. In addition, pharmacists are uniquely positioned to intervene and encourage caregivers to take their medicine because the caregiver is often the person who is picking up medications for both family members and themselves."
About CVS Caremark
CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,200 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.
Media Contact:Jon SandbergCVS Caremark(401)770 email@example.com
SOURCE CVS Caremark
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All